Myda Advisors LLC Vir Biotechnology, Inc. Transaction History

Myda Advisors LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$28.28 - $53.6 $339,360 - $643,200	-12,000 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$27.89 - $47.86 $125,505 - $215,370	4,500 Added 60.0%	12,000 $492,000
Q1 2020 May 14, 2020	BUY	$12.04 - $60.2 $90,300 - $451,500	7,500 New	7,500 $257,000

219

87.4M

127K

1.19M

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $944M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Myda Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Myda Advisors LLC with notifications on news.